Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06731764 · ClinicalTrials.gov registry record · Phase 2
Novel Approaches to the Treatment of Hypothyroidism
A Phase 2 study of Hypothyroidism, sponsored by UConn Health.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT06731764: Recruiting Phase 2 study of Hypothyroidism, sponsored by UConn Health.
NCT06731764 is a Phase 2 study of Hypothyroidism that is actively recruiting participants, run by UConn Health. The registered enrollment target is 90 participants, below the 819-participant average among 9 other Hypothyroidism trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06731764, a Phase 2 study of Hypothyroidism, is actively recruiting participants, sponsored by UConn Health.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
Hypothyroidism is a common condition, more frequent in females, associated with excess of cardiovascular risk and poor quality of life not completely abrogated by treatment with levothyroxine. There is an unmet need to define a safe, effective, and feasible regimen to be applied in large trials aimed at assessing levothyroxine/liothyronine combination therapy in patients living with hypothyroidism. To address this knowledge gap we propose a randomized, three-arm, double-blind, controlled, escalating dose parallel pilot study whose results will lay the foundation of large multicenter trial(s) able to demonstrate the effectiveness (or lack thereof) of levothyroxine/liothyronine combination therapy.
Primary Outcome
Changes between groups
Conditions Studied
Interventions
- DRUG Levothyroxine
- DRUG Levothyroxine/Liothyronine once daily
- DRUG Levothyroxine/Liothyronine twice daily
Study Locations (1)
Connecticut
- UConn Health - Farmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2024-12-10 |
| Est. Completion | 2028-06-30 |
| Phase | Phase 2 |
What NCT06731764 shows while recruiting
NCT06731764 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 819-participant average among 9 other Hypothyroidism trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Hypothyroidism appearing as the primary indexed condition, and to 3 interventions - of which Levothyroxine is the first listed.
NCT06731764 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06731764 about?
NCT06731764 is a clinical study titled "Novel Approaches to the Treatment of Hypothyroidism". Hypothyroidism is a common condition, more frequent in females, associated with excess of cardiovascular risk and poor quality of life not completely abrogated by treatment with levothyroxine. There is an unmet need to define a safe, effective, and feasible regimen to be applied in large trials aim...
What is the current status of trial NCT06731764?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 90 participants. The study started on 2024-12-10. Estimated completion is 2028-06-30.
What conditions does trial NCT06731764 study?
This clinical trial studies the following conditions: Hypothyroidism.
What interventions are being tested in trial NCT06731764?
The interventions under investigation include: Levothyroxine (DRUG), Levothyroxine/Liothyronine once daily (DRUG), Levothyroxine/Liothyronine twice daily (DRUG).
Who is sponsoring clinical trial NCT06731764?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06731764 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypothyroidism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06731764's enrollment target sits among peer trials
90 7th of 9 higher than 3 of 9 other Hypothyroidism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypothyroidism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
RECRUITING · Phase 2
-
Energy Metabolism in Thyroidectomized Patients
COMPLETED · Phase 2
-
Optimizing Care for Older Adults Through Thyroid Hormone Deprescribing
RECRUITING · NA
-
A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
RECRUITING · NA
-
Natural History of Thyroid Function Disorders
RECRUITING
-
Dosing of LT4 in Older Individuals
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI